Great Point Partners’s Cartesian Therapeutics RNAC Stock Holding History

Great Point Partners’s Portfolio RNAC Stock Details RNAC Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$3.22M	Buy
2018 Q1	–	Sell
2017 Q4	$1.75M	Sell
2017 Q3	$16.5M	Sell
2017 Q2	$18.6M	Buy